Today, Phillip Md Et Al Frost Buys 4,300 Shares of Opko Health Inc. (OPK) Stock

Today, Phillip Md Et Al Frost Buys 4,300 Shares of Opko Health Inc. (OPK) Stock

Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost acquired 4,300 shares of the business’s stock in a transaction on Wednesday, November 23rd. The stock was acquired at an average price of $10.09 per share, with a total value of $43,387.00. Following the transaction, the chief executive officer now owns 3,068,951 shares in the company, valued at approximately $30,965,715.59. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Phillip Md Et Al Frost also recently made the following trade(s): On Tuesday, November 22nd, Phillip Md Et Al Frost acquired 5,400 shares of Opko Health stock. The stock was acquired at an average price of $10.28 per share, with a total value of $55,512.00. On Monday, November 21st, Phillip Md Et Al Frost acquired 3,600 shares of Opko Health stock. The stock was acquired at an average price of $10.41 per share, with a total value of $37,476.00. On Friday, November 18th, Phillip Md Et Al Frost acquired 1,800 shares of Opko Health stock. The stock was acquired at an average price of $10.38 per share, with a total value of $18,684.00. On Wednesday, November 16th, Phillip Md Et Al Frost acquired 4,300 shares of Opko Health stock. The stock was acquired at an average price of $10.13 per share, with a total value of $43,559.00. On Friday, November 11th, Phillip Md Et Al Frost acquired 14,600 shares of Opko Health stock. The stock was acquired at an average price of $9.46 per share, with a total value of $138,116.00. On Wednesday, November 9th, Phillip Md Et Al Frost bought 5,400 shares of Opko Health stock. The shares were purchased at an average price of $9.33 per share, with a total value of $50,382.00. On Tuesday, November 8th, Phillip Md Et Al Frost bought 23,100 shares of Opko Health stock. The shares were purchased at an average price of $9.22 per share, with a total value of $212,982.00. On Wednesday, November 2nd, Phillip Md Et Al Frost bought 10,000 shares of Opko Health stock. The shares were purchased at an average price of $9.48 per share, with a total value of $94,800.00. On Tuesday, November 1st, Phillip Md Et Al Frost bought 10,000 shares of Opko Health stock. The shares were purchased at an average price of $9.49 per share, with a total value of $94,900.00. On Monday, October 31st, Phillip Md Et Al Frost bought 11,800 shares of Opko Health stock. The shares were purchased at an average price of $9.43 per share, with a total value of $111,274.00.

Shares of Opko Health Inc. (NASDAQ:OPK) opened at 10.62 on Tuesday. The stock has a 50 day moving average price of $9.76 and a 200-day moving average price of $9.88. The company’s market capitalization is $5.92 billion. Opko Health Inc. has a one year low of $7.12 and a one year high of $11.85.

Opko Health (NASDAQ:OPK) last announced its quarterly earnings results on Monday, November 7th. The company reported ($0.03) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.03). Opko Health had a negative return on equity of 0.49% and a negative net margin of 0.81%. The company earned $298 million during the quarter, compared to analysts’ expectations of $322 million. During the same period in the prior year, the company earned $0.25 EPS. Opko Health’s revenue was up 108.4% compared to the same quarter last year. On average, equities research analysts expect that Opko Health Inc. will post ($0.08) EPS for the current year.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. LPL Financial LLC boosted its position in shares of Opko Health by 3.9% in the third quarter. LPL Financial LLC now owns 13,374 shares of the company’s stock worth $142,000 after buying an additional 504 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Opko Health by 3.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 947,871 shares of the company’s stock worth $10,038,000 after buying an additional 28,700 shares during the last quarter. Piedmont Investment Advisors LLC purchased a new position in shares of Opko Health during the third quarter worth approximately $622,000. Finally, Whalerock Point Partners LLC purchased a new position in shares of Opko Health during the third quarter worth approximately $2,100,000. Institutional investors own 22.27% of the company’s stock.

A number of equities research analysts recently commented on the company. Oppenheimer Holdings Inc. reaffirmed a “market perform” rating on shares of Opko Health in a research note on Thursday, August 11th. Jefferies Group reaffirmed a “hold” rating and set a $10.00 price objective on shares of Opko Health in a research note on Monday, October 10th. TheStreet cut Opko Health from a “hold” rating to a “sell” rating in a research note on Wednesday, November 9th. Zacks Investment Research cut Opko Health from a “hold” rating to a “sell” rating in a research note on Wednesday, October 19th. Finally, JPMorgan Chase & Co. set a $14.00 price objective on Opko Health and gave the stock a “buy” rating in a research note on Tuesday, August 9th. One analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the company. Opko Health has a consensus rating of “Hold” and a consensus target price of $13.17.

Opko Health Company Profile

Related posts

Leave a Comment